Antibody

  • Antibody Drug Conjugate

    Antibody Drug Conjugate

    Antibody Drug Conjugate (ADCs) are monoclonal antibodies attached to biologically active drugs by chemical linkers.  These cytotoxic killers are a new frontier in immunotherapy offering tissue targeting capabilities for superior immunological response. Explore the 3D structure of an Antibody Drug Conjugate to learn more about how it combats cancer.

     

  • 5DK3, 5GGS, Pembrolizumab, Keytruda, Biologic Models, IgG4, monoclonal antibody

    Monoclonal IgG4 Antibody bound to PD1

    This is a 3D print of a humanized monoclonal IgG4 antibody used in multiple types of cancer treatments. Models available in multiple materials and sizes.

  • MT-3724 Immunotoxin

    Protein Description This cytotoxic drug utilizes Molecular Templates an innovative Engineered Toxic Bodies (ETBs) drug delivery platform to trigger cell death. MT-3724 is being developed for the treatment of non-Hodgkin’s Lymphoma and harnesses the immunotherapy power of antibody receptor-specific targeting combined, a bacterial process for cell invasion that infects cancer cells with ribosomal inhibitors that […]